Cargando…

Cytogenetic study in CML

Detalles Bibliográficos
Autor principal:	Subramanian, P.G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307171/ https://www.ncbi.nlm.nih.gov/pubmed/22382177 http://dx.doi.org/10.4103/0971-5916.93418

Ejemplares similares

Cytogenetic alterations in CML: not all created equal
por: Gong, Zimu, et al.
Publicado: (2018)

“Classical cytogenetics” is not equal to “banding cytogenetics”
por: Liehr, Thomas
Publicado: (2017)

American Society of Hematology 2020 Podcast Collection: CML
por: Breccia, Massimo
Publicado: (2021)

CNL and aCML are prognostically distinct: a large National Cancer Database analysis
por: Tremblay, Douglas, et al.
Publicado: (2023)

A study to determine the clinical, hematological, cytogenetic, and molecular profile in CML patient in and around Eastern UP, India
por: Kumar, Sandip, et al.
Publicado: (2019)

PB2223: CLINICOPATHOLOGICAL, CYTOGENETIC AND MOLECULAR CHARACTERISTICS OF PATIENTS WITH NON-CML MYELOPROLIFERATIVE NEOPLASMS: A SINGLE CENTER STUDY
por: Guntiboina, Vinay Anand, et al.
Publicado: (2023)

Application of Decision-Analytic Models in Personalized Medicine for CML Treatment Decisions Made by Payers, Providers, and Patients
por: Saverno, Kim R., et al.
Publicado: (2012)

About classical molecular genetics, cytogenetic and molecular cytogenetic data not considered by Genome Reference Consortium and thus not included in genome browsers like UCSC, Ensembl or NCBI
por: Liehr, Thomas
Publicado: (2021)

Cytogenetics in paediatric aplastic anaemia: Does it give an insight on the evolution of the disease?
por: Ghosh, Kanjaksha
Publicado: (2013)

Cytogenetic and Molecular Analyses of Philadelphia Chromosome Variants in CML (chronic myeloid leukemia) Patients from Sindh using Karyotyping and RT-PCR
por: Ujjan, Ikram Din, et al.
Publicado: (2015)

COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): Results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study
por: Rea, Delphine, et al.
Publicado: (2020)

CML: Evolution and design
por: Murray-Rust, Peter, et al.
Publicado: (2011)

How I Manage Patients with Chronic Myeloid Leukemia (CML): Perspectives from Clinical Practice
por: Guru Murthy, Guru Subramanian
Publicado: (2022)

New concepts for CML clonality
por: Khorashad, Jamshid S., et al.
Publicado: (2013)

Eradication of CML stem cells
por: Carter, Bing Z., et al.
Publicado: (2016)

Current treatment approaches in CML
por: Castagnetti, Fausto, et al.
Publicado: (2019)

Interactions between RSV Infection, Asthma, and Atopy: Unraveling the Complexities
por: Holt, P.G., et al.
Publicado: (2002)

Cytogenetics
por: Swanson, Carl P.
Publicado: (1967)

The incidence of atypical patterns of BCR-ABL1 rearrangement and molecular-cytogenetic response to tyrosine kinase inhibitor therapy in newly diagnosed cases with chronic myeloid leukemia (CML)
por: Švabek, Željka Tkalčić, et al.
Publicado: (2018)

CMLLite: a design philosophy for CML
por: Townsend, Joe A, et al.
Publicado: (2011)

Chronic Myelogenous Leukemia (CML) in the elderly
por: Balducci, Lodovico, et al.
Publicado: (2014)

The New ELN Recommendations for Treating CML
por: Hehlmann, Rüdiger
Publicado: (2020)

Intrapatient competition of VEXAS syndrome and CML clones
por: Djerbi, Nadia, et al.
Publicado: (2023)

Cytology and cytogenetics.
por: Swanson, Carl P.
Publicado: (1957)

Platform trials as the way forward in infectious disease’ clinical research: the case of coronavirus disease 2019
por: Pericàs, Juan M., et al.
Publicado: (2023)

On the Power of Additional and Complex Chromosomal Aberrations in CML
por: Greulich-Bode, Karin M, et al.
Publicado: (2012)

Growth effect of tki treatment in childhood CML
por: Jeon, Yeon Jin, et al.
Publicado: (2015)

Cobll1: A new player in CML
por: Kim, Hongtae, et al.
Publicado: (2017)

MEK/ERK addiction in CNL/aCML
por: Kesarwani, Meenu, et al.
Publicado: (2017)

Molecular response prediction in CML: novel ideas?
por: Wolf, Dominik, et al.
Publicado: (2017)

Epigenetic Reprogramming and Emerging Epigenetic Therapies in CML
por: Bugler, Jane, et al.
Publicado: (2019)

Comparison of the Transcriptomic Signatures in Pediatric and Adult CML
por: Youn, Minyoung, et al.
Publicado: (2021)

NGS in CML - New standard diagnostic procedure?
por: Branford, Susan, et al.
Publicado: (2019)

PB1891: VARIANT PHILADELPHIA CHROMOSOME IN CML
por: Bouayed Abdelmoula, N., et al.
Publicado: (2022)

The expanding CML treatment landscape: an introspective commentary
por: Lipton, Jeffrey H.
Publicado: (2023)

Role of cytogenetic abnormalities detected by fluorescence in situ hybridization as a prognostic marker: Pathogenesis & clinical course in patients with B-chronic lymphocytic leukaemia
por: Shetty, Dhanlaxmi, et al.
Publicado: (2021)

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
por: Hehlmann, R, et al.
Publicado: (2017)

The Ca(2+) sensor proteins CML37 and CML42 antagonistically regulate plant stress responses by altering phytohormone signals
por: Heyer, Monika, et al.
Publicado: (2021)

The Efficacy of Reduced-dose Dasatinib as a Subsequent Therapy in Patients with Chronic Myeloid Leukemia in the Chronic Phase: The LD-CML Study of the Kanto CML Study Group
por: Iriyama, Noriyoshi, et al.
Publicado: (2017)

Contributions of Cytogenetics and Molecular Cytogenetics to the Diagnosis of Adipocytic Tumors
por: Nishio, Jun
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0ca8t0bpkl46suo53rh6ftf2h3